| __timestamp | BioCryst Pharmaceuticals, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 13486000 | 63900978 |
| Thursday, January 1, 2015 | 46361000 | 106145897 |
| Friday, January 1, 2016 | 23654000 | 49646515 |
| Sunday, January 1, 2017 | 23484000 | 66757840 |
| Monday, January 1, 2018 | 20182000 | 74645876 |
| Tuesday, January 1, 2019 | 44734000 | 59670105 |
| Wednesday, January 1, 2020 | 16136000 | 318524319 |
| Friday, January 1, 2021 | 149906000 | 147400000 |
| Saturday, January 1, 2022 | 264233000 | 229647003 |
| Sunday, January 1, 2023 | 326751000 | 179923313 |
Unleashing insights
In the competitive landscape of biotechnology, understanding financial health is crucial. This analysis compares the gross profit trends of MorphoSys AG and BioCryst Pharmaceuticals, Inc. from 2014 to 2023. Over this period, MorphoSys AG demonstrated a steady growth trajectory, peaking in 2020 with a gross profit of approximately 318 million. However, BioCryst Pharmaceuticals, Inc. showed a remarkable surge, especially from 2021 onwards, culminating in a 2023 gross profit of around 327 million, marking a 146% increase from 2014. This shift highlights BioCryst's strategic advancements in the biotech sector. While MorphoSys maintained a consistent performance, BioCryst's recent growth suggests a dynamic shift in market positioning. Investors and stakeholders should note these trends as they reflect broader industry movements and potential future opportunities.
Key Insights on Gross Profit: Amgen Inc. vs MorphoSys AG
Gilead Sciences, Inc. vs MorphoSys AG: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Vertex Pharmaceuticals Incorporated or MorphoSys AG
Gross Profit Trends Compared: Biogen Inc. vs BioCryst Pharmaceuticals, Inc.
Incyte Corporation and MorphoSys AG: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Dr. Reddy's Laboratories Limited and MorphoSys AG
Key Insights on Gross Profit: Catalent, Inc. vs BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for MorphoSys AG and BioCryst Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.
Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: BioCryst Pharmaceuticals, Inc. and Evotec SE Trends